MAPT and Alzheimer disease: Co-staining of AD brain sections with immune sera and various anti-tau antibodies (total htau, pS199/202 and pS396/404) further demonstrated co-localization of tau recognized by anti-tau2-18 sera and these antibodies within NFTs and dystrophic neurites (Fig. 3b–d).